Anticoagulation/Thromboembolism
RSSArticles
-
Subclinical Leaflet Thrombosis: Not Just a TAVR Phenomenon
Imaging-defined leaflet thrombosis was common and similar between transcatheter aortic valve replacement and surgical aortic valve replacement bioprosthetic valves. These findings showed no apparent relationship to valve hemodynamics or to clinical outcomes, including stroke.
-
Heart Failure Confers Increased Risk of Venous Thromboembolic Events
In the Atherosclerosis Risk in Communities (ARIC) cohort, incident heart failure hospitalization with either preserved or reduced ejection fraction was associated with long-term increased risk of venous thromboembolic events.
-
Group Leads Charge Against Venous Thromboembolism
The American Heart Association issues guidance to help prevent a common and costly hospital-acquired condition.
-
Warfarin vs. DOAC for Left Ventricular Thrombi
A large, multicenter, observational study of the relative efficacy of warfarin vs. direct oral anticoagulants (DOACs) for left ventricular thrombi has shown that DOAC use is associated with a higher risk of embolic events than warfarin. Investigators advised caution with off-label use of DOACs.
-
Does Anticoagulant Therapy Affect Outcomes in Left Ventricular Mural Thrombus Patients?
Left ventricular thrombus is an uncommon finding but one associated with a high incidence of all-cause mortality and major adverse cardiac and embolic events. Total regression of left ventricular thrombus on anticoagulant therapy reduced mortality.
-
A Review of Atrial Fibrillation and Current Therapeutic Strategies: Part 2
This two-part series presents a review of the current evidence on atrial fibrillation (AF). The first part included the definition of AF, its classification, risk factors, comorbidities, evaluation, and acute management of newly diagnosed patients. The second part focuses on long-term management, including risk factor modification, rate and rhythm control measures, stroke risk stratification, and anticoagulation management.
-
Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft
The data from this study do not indicate that new-onset postoperative atrial fibrillation should be regarded as having the same risks as primary nonvalvular atrial fibrillation in terms of long-term thromboembolic risk, and that anticoagulation in this group may not be necessary unless the atrial fibrillation is persistent.
-
Utility of the New Cholesterol Guidelines
The American College of Cardiology/American Heart Association (ACC/AHA) released new guidelines for the use of statin drugs to prevent atherosclerotic cardiovascular disease (CVD) in 2013.
-
Delays in Transfer For Primary PCI in STEMI
Most patients with ST-elevation myocardial infarction (STEMI) present to hospitals that are not capable of percutaneous coronary intervention (PCI). Rapid transfer to PCI-capable facilities for primary PCI may result in earlier reperfusion of the infarct artery and better clinical outcomes. However, delays in transfer may diminish the mortality benefit achieved with primary PCI in STEMI. -
Assessment of Functional Severity of Coronary Lesions by CT Angiography — FFRCT
Anatomic definition of coronary artery lesions by invasive coronary angiography (ICA) or computed tomography coronary angiography (CCTA) has limitations.